We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for Kimberly-Clark (KMB) Q3 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Kimberly-Clark (KMB - Free Report) will report quarterly earnings of $1.66 per share in its upcoming release, pointing to a year-over-year decline of 8.8%. It is anticipated that revenues will amount to $4.15 billion, exhibiting a decrease of 0.1% compared to the year-ago quarter.
The current level reflects a downward revision of 1.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Kimberly-Clark metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Net Sales- International Personal Care (IPC)' will reach $1.43 billion. The estimate suggests a change of -0.6% year over year.
The collective assessment of analysts points to an estimated 'Net Sales- North America (NA)' of $2.72 billion. The estimate suggests a change of +0.1% year over year.
According to the collective judgment of analysts, 'Operating Profit- International Personal Care (IPC)' should come in at $198.40 million. Compared to the present estimate, the company reported $214.00 million in the same quarter last year.
Analysts predict that the 'Operating Profit- North America (NA)' will reach $649.91 million. The estimate is in contrast to the year-ago figure of $640.00 million.
Over the past month, shares of Kimberly-Clark have returned +13.5% versus the Zacks S&P 500 composite's -2.3% change. Currently, KMB carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Gear Up for Kimberly-Clark (KMB) Q3 Earnings: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Kimberly-Clark (KMB - Free Report) will report quarterly earnings of $1.66 per share in its upcoming release, pointing to a year-over-year decline of 8.8%. It is anticipated that revenues will amount to $4.15 billion, exhibiting a decrease of 0.1% compared to the year-ago quarter.
The current level reflects a downward revision of 1.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Kimberly-Clark metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Net Sales- International Personal Care (IPC)' will reach $1.43 billion. The estimate suggests a change of -0.6% year over year.
The collective assessment of analysts points to an estimated 'Net Sales- North America (NA)' of $2.72 billion. The estimate suggests a change of +0.1% year over year.
According to the collective judgment of analysts, 'Operating Profit- International Personal Care (IPC)' should come in at $198.40 million. Compared to the present estimate, the company reported $214.00 million in the same quarter last year.
Analysts predict that the 'Operating Profit- North America (NA)' will reach $649.91 million. The estimate is in contrast to the year-ago figure of $640.00 million.
View all Key Company Metrics for Kimberly-Clark here>>>Over the past month, shares of Kimberly-Clark have returned +13.5% versus the Zacks S&P 500 composite's -2.3% change. Currently, KMB carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .